The global antibody therapeutics market is witnessing a period of significant growth. This momentum can be attributed to several factors, like the increasing prevalence of chronic diseases, advancements in biotechnology, and growing acceptance of biologics. The market is estimated to expand at a growth rate of Z% during the forecast period, driven